Condition: Cystic Fibrosis-related Diabetes · Cystic Fibrosis · Sponsor: University of Kansas Medical Center
The purpose of this study is to assess the efficacy of metformin to improve airway ion channel function in those with CF-related diabetes (CFRD)
This description comes directly from the study's public registry record.
Matthias A Salathe, M.D. · 9135886000 · msalathe@kumc.edu
Carolina Aguiar · 9139459295 · caguiar@kumc.edu
Always discuss trial participation with your own doctor first.
| University of Kansas Medical Center | Kansas City, Kansas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04530383